Showing results (341-350 of 386) with videos related to
Sort By:
Pageof 39
Transplantation Proceedings|March 1, 1977
Specific absorbed antithymocyte globulin for incubation treatment in human marrow transplantationH Rodt, B Netzel, D Niethammer, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 21, 2010
Analysis of differentially expressed proteins in oral squamous cell carcinoma by MALDI-TOF MSUta J E Thiel, Ralph Feltens, Boris Adryan, et al.British Journal of Haematology|May 1, 1997
Morphological and cytochemical findings in 150 cases of T-lineage acute lymphoblastic leukaemia in adults. German Multicentre ALL Study Group (GMALL)W Gassmann, H Löffler, E Thiel, et al.Leukemia & Lymphoma|February 26, 1998
Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemiaW U Knauf, I Langenmayer, B Ehlers, et al.Blood|April 1, 1989
Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemiaE Thiel, B R Kranz, A Raghavachar, et al.International Journal of Cancer|April 9, 1998
De novo expression of the alpha5beta1-fibronectin receptor in HT29 colon-cancer cells reduces activity of C-SRC. Increase of C-SRC activity by attachment on fibronectinR Schmidt, M Streit, R Kaiser, et al.British Journal of Haematology|August 1, 1996
Interferon-alpha 2b (IFN alpha) for early-phase chronic lymphocytic leukaemia with high risk for disease progression: results of a randomized multicentre studyI Langenmayer, C Nerl, W Knauf, et al.Science and Engineering Ethics|October 16, 2012
Effects of alternative outcome scenarios and structured outcome evaluation on case-based ethics instructionJuandre Peacock, Lauren N Harkrider, Zhanna Bagdasarov, et al.Eye (London, England)|March 27, 2007
Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastasesU Petrausch, P Martus, H Tönnies, et al.Leukemia & Lymphoma|December 3, 2005
Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetanT Fietz, L Uharek, C Gentilini, et al.Pageof 39